Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

35,144 signal articles · 106 in last 24h · 178,660 total before filter · latest 1h ago

106last 24h

3125last 7d

511● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1819 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: AMGNSentiment:bullish neutral bearish show all (incl. clickbait)

MT Newswires3d agoneutral

Guggenheim Adjusts Price Target on Amgen to $435 From $378

AMGN

MT Newswires4d agoneutral

Scotiabank Adjusts Price Target on Amgen to $530 From $500

AMGN

MT Newswires4d agoneutral

BofA Securities Adjusts Price Target on Amgen to $347 From $328

AMGN

MT Newswires4d agoneutral

Morgan Stanley Adjusts Price Target on Amgen to $410 From $359

AMGN

MT Newswires4d agoneutral

Truist Adjusts Price Target on Amgen to $398 From $380

AMGN

MT Newswires4d agoneutral

Wells Fargo Adjusts Price Target on Amgen to $460 From $430

AMGN

MT Newswires4d agoneutral

Oppenheimer Adjusts Amgen Price Target to $520 From $480

AMGN

MT Newswires4d agoneutral

TD Cowen Adjusts Price Target on Amgen to $531 From $452

AMGN

MT Newswires4d agoneutral

Goldman Sachs Adjusts Price Target on Amgen to $536 From $481

AMGN

MT Newswires4d agoneutral

BMO Capital Adjusts Price Target on Amgen to $442 From $415

AMGN

MT Newswires4d agoneutral

JPMorgan Adjusts Price Target on Amgen to $425 From $350

AMGN

MT Newswires4d agoneutral

UBS Adjusts Price Target on Amgen to $530 From $470

AMGN

MT Newswires4d agoneutral

Bernstein Adjusts Price Target on Amgen to $400 From $345

AMGN

MT Newswires4d agoneutral

Canaccord Genuity Adjusts Price Target on Amgen to $440 From $384

AMGN

MT Newswires4d agoneutral

RBC Capital Adjusts Price Target on Amgen to $470 From $430

AMGN

MT Newswires4d agoneutral

Citigroup Adjusts Price Target on Amgen to $465 From $405

AMGN

Proactive46d agoneutral

Amgen price target raised by Jefferies to $410 after positive Sjögren's data

AMGN

Investing.com59d agobearish

HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review

AMGN

InvestorsHub61d agobearish

Amgen Shares Fall as Investors Assess Novartis Lp(a) Trial Result and BMO Downgrade

AMGN

24/7 Wall St.188d agoneutral

Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?

AMGN LLY NVO